Getein Anti-HCV Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of hepatitis C.
Anti-HCV Fast Test Kit
(Immunofluorescence Assay)
Intended Use
Anti-HCV Fast Test Kit (lmmunofluorescence Assay) is intend-ed for in vitro quantitative determination of hepatitis C virus (HCV) antibody in serum or plasma samples.
About Anti-HCV
HCV is spherical, less than 80 nm in diameter (36 to 40 nm inhepatocytes,36-62 nm in blood), is a single-stranded positive-strand RNA virus, and is surrounded by a lipid-containing capsule in the nucleocapsid. Hepatitis C is a viral hepatitis caused by HCV infection, which is mainly transmitted by blood transfusion, acupuncture and drug use. Hepatitis C is globally prevalent and can cause chronic inflammation, necrosis and fibro-sis in the liver. Some patients can develop cirrhosis or even hepatocellular carcinoma. The mortality associated with HCV infection (hepatic failure and death from hepatocellular carcinoma) will continue to increase in the next 20 years, which is extremely harmful to patients' health and life.
HCV has high variability, and there is no effective hepatitis c vaccine available. Therefore, it is particularly important to pre-vent and control the infection and spread of hepatitis C. As an important hepatitis C marker, HCV antibody is one of the most important diagnostic methods for hepatitis C.
Contents
For Getein1100/Getein1180
Package specifications: 10 tests/box, 25 tests/box
1) Getein Anti-HCV test card in a sealed pouch with desiccant.
2) Disposable pipet
3) User Manual:1 piece/box
4) SD card: 1 piece/box
Note: Do not mix or interchange different batches of kits.
Specifications
Test Item |
Sample |
Detection Range |
Storage Condition |
Anti-HCV |
S/P |
1.00-20.00 S/CO |
4-30℃ |
Method |
Test Time |
Cut-off Value |
Shelf Life |
Immunofluorescence Assay |
15 min |
<1.00 S/CO |
24 months |
Applicable Device
Getein1100 Immunofluorescence Quantitative Analyzer
Getein1180 Immunofluorescence Quantitative Analyzer
Clinical Application
As an aid in the clinical diagnosis, prognosis and evaluation of hepatitis C.